EXHIBIT 99.1
IMMEDIATE RELEASE    

Sharps Compliance Reports Fiscal 2019 First Quarter Results
First quarter 2019 revenue increased to $10.3 million with gross margin of 33%, net income of $0.1 million and break-even net income per share
Unused Medication solutions business increased 40%
Route-based business increased 21%
Unused medication management and route-based services represented 37% of the Company’s September 2018 quarter customer billing
MedSafe collection receptacles installed base of 2,800 units versus 1,400 a year ago; Surpassed the 20,000 mark for returned MedSafe liners
Retail market billings increased 61%
Professional market billings increased 19%
Pharma Manufacturer billings lower due to timing of inventory builds

HOUSTON, Texas, October 24, 2018 - Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today reported financial results for the first quarter of fiscal year 2019, which ended September 30, 2018.
Revenue in the first quarter of fiscal 2019 increased 6.3% to $10.3 million, as compared to revenue of $9.7 million in the same prior year quarter, driven primarily by a $0.5 million increase in flu shot related orders and a $0.5 million increase in orders related to the Company’s Unused Medication solutions partially offset by lower billings to Pharma Manufacturers due to the timing of inventory builds. The Company reported operating income of $0.1 million in the first quarter of fiscal 2019, consistent with operating income in the first quarter of fiscal 2018. Sharps recorded net income of $0.1 million or $0.00 per basic and diluted share in the first quarter of fiscal 2019, as compared to net income of $0.1 million or $0.00 per basic and diluted share in the first quarter of fiscal 2018.
David P. Tusa, President and Chief Executive Officer of Sharps, stated, “We’re pleased to start the fiscal 2019 with a strong first quarter. Over the past few years, we’ve strategically broadened our portfolio of solutions, growing from primarily a mailback company to our position now as a leading comprehensive provider of medical and pharmaceutical waste management services. While we benefitted from flu shot related orders this quarter, there is variability in that part of our business and we remain focused on growing our route-based and unused medication solutions, both of which contribute much more predictable, recurring revenue. During the first quarter, we added Florida to our route-based pick-up footprint and we now cover 24 states or 55% of the population. Furthermore, we’re seeing intensified demand for our unused medication solutions as communities and healthcare providers work to address the growing epidemic of prescription drug abuse and accidental poisonings. Last week, we announced our support of the DEA’s National Prescription Drug Take Back Day, scheduled to take place on October 27. As part of that announcement, we noted our Company milestone of having properly processed and treated more than 2.7 million pounds of unused medications since 2009 through the use of our MedSafe and TakeAway Medication Recovery System Envelopes. The Company has sold more than 3.4 million of its TakeAway Medication Recovery System Envelopes, installed 2,800 MedSafe units and has processe





d over 20,000 MedSafe liners. Through our leadership position, we are committed to increasing the role our solutions play in assisting the effort to fight the national opioid crisis.”
First Quarter Review
Professional market billings increased 19% to $3.7 million in the first quarter of fiscal 2019 compared to $3.1 million in the prior year period. This increase represents organic growth related to the Company’s focus on securing customers from the small to medium quantity generator sector made up of physicians, clinics, dentists, surgery centers, veterinarians and other healthcare professionals, who typically use a combination of the cost-effective and convenient Sharps Recovery System™ and the Company’s route-based pick-up services. The inside and online sales channel, which primarily targets the Professional and Government markets, achieved a 33% increase in billings to $2.3 million in the first quarter of fiscal 2019 as compared to $1.7 million in the same prior year period.
Retail market billings increased by 61% to $2.3 million compared with $1.4 million in the prior year period. The increase is primarily related to flu shot related orders which increased by about $0.5 million, from $0.7 million in the prior year to $1.2 million in the current year, and increases in orders of $0.5 million for unused medication solutions including the MedSafe in the Retail pharmacy market.
Pharmaceutical Manufacturer billings decreased 47% to $0.8 million in the first quarter of fiscal 2019 compared to $1.5 million in the first quarter of fiscal 2018. The decrease is related to the timing of inventory builds.
Government billings increased 8% to $0.6 million in the first quarter of fiscal 2019. Government market billings included $0.1 million of orders under the VA’s Blanket Purchase Agreement, consistent with orders in the first quarter of fiscal 2018. MedSafe related orders to the government market were $0.3 million for the first quarter of fiscal 2019, up slightly compared with billings in the first quarter of fiscal 2018.
Additional Operating Results
Gross margin increased to 33% for the first quarter of fiscal 2019, compared to gross margin of 31% in the same prior year quarter. SG&A increased to $3.0 million, or 29% of revenue, for the first quarter of fiscal 2019 as compared to SG&A of $2.7 million, or 28% of revenue, in the same prior year quarter due to our continued investment in sales and marketing.
Sharps recorded EBITDA of $0.5 million in the first quarter of fiscal 2019, consistent with EBITDA in the first quarter of fiscal 2018. (See Reconciliation of Net Income to EBITDA in the supplemental table included at the end of this release).
Financial Flexibility and a Strong Balance Sheet
Cash was $5.1 million at September 30, 2018 compared with $5.2 million at June 30, 2018. The Company had working capital of $10.9 million at September 30, 2018 compared to $10.3 million at June 30, 2018.
Looking Forward
Mr. Tusa concluded, “As we move through fiscal 2019, we believe we are well positioned to leverage four primary revenue streams to drive growth including our traditional medical waste mailback, route-based medical waste pick-up services, unused medication management solutions and the new single use device recycling system. We are focused on growth in all markets through increased sales and marketing of the solution offerings driving these four revenue streams. The management team is energized and excited about the prospects for the Company in fiscal 2019 and beyond in the markets we serve.”





First Quarter Fiscal Year 2019 Webcast and Conference Call
The Company will host a teleconference today beginning at 11:00 a.m. Eastern Time, during which management will review the financial and operating results for the period and discuss Sharps’ corporate strategy and outlook. A question-and-answer session will follow.
The Sharps conference call can be accessed by domestic callers by dialing (877) 407-0782. International callers may access the call by dialing (201) 689-8567. The webcast can be monitored at www.sharpsinc.com.

A telephonic replay will be available through November 24, 2018. To listen to the replay, domestic callers should dial (877) 481-4010 and international callers should dial (919) 882-2331 and enter replay ID number 38546. Transcript will also be posted to the Sharps website, once available.

About Sharps Compliance Corp.
Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living / long-term care, surgery centers, retail pharmacies and clinics, and the professional market which is comprised of physicians, dentists and veterinary practices. The Company's flagship product, the Sharps Recovery System, is a comprehensive solution for the containment, transportation, treatment and tracking of medical waste and other used healthcare materials. The Company also offers its route-based pick-up service in a twenty-four (24) state region of the South, Southeast and Northeast portions of the United States.
More information on the Company and its products can be found on its website at: www.sharpsinc.com
Safe Harbor Statement
The information made available in this news release contains certain forward-looking statements which reflect Sharps Compliance Corp.’s current view of future events and financial performance. Wherever used, the words “estimate,” “expect,” “plan,” “anticipate,” “believe,” “may” and similar expressions identify forward-looking statements. Any such forward-looking statements are subject to risks and uncertainties and the Company’s future results of operations could differ materially from historical results or current expectations. Some of these risks include, without limitation, the Company’s ability to educate its customers, development of public awareness programs to educate the identified consumer, customer preferences, the Company’s ability to scale the business and manage its growth, the degree of success the Company has at gaining more large customer contracts, managing regulatory compliance and/or other factors that may be described in the Company’s annual report on Form 10-K, quarterly reports on Form 10-Q and/or other filings with the Securities and Exchange Commission. Future economic and industry trends that could potentially impact revenue and profitability are difficult to predict. The Company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results, express or implied therein, will not be realized.
Non-GAAP Measures
This release contains certain financial information not derived in accordance with generally accepted accounting principles (“GAAP”), including customer billings information, EBITDA and non-GAAP net income per share. The Company believes this information is useful to investors and other interested parties. EBITDA is a significant performance metric used by management and by external users of our financial





statements such as investors, research analysts and others to assess the financial performance of our assets without regard to financing methods, capital structure or historical cost basis; the ability of our assets to generate cash sufficient to pay interest costs and support our indebtedness; and our operating performance and return on capital as compared to those of other companies in our industry. Such information should not be considered as a substitute for any measure derived in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Reconciliation of this information to the most comparable GAAP measures is included as an attachment to this release.
For more information contact:
 

Diana P. Diaz
Sharps Compliance Corp.
Vice President and Chief Financial Officer
Phone: (713) 660-3547
Email: ddiaz@sharpsinc.com
John Nesbett/Jennifer Belodeau
Institutional Marketing Services (IMS)
Phone: (203) 972-9200
Email: jnesbett@institutionalms.com
FINANCIAL TABLES FOLLOW







Sharps Compliance Corp. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(Unaudited)

 
Three-Months Ended
 
 
September 30,
 
 
2018
 
2017
% Change
 
 
 
 
 
Revenue
$
10,293

 
$
9,683

6.3
%
 
 
 
 
 
Cost of revenue
6,941

 
6,655

4.3
%
Gross profit
3,352

 
3,028

10.7
%
Gross margin
32.6
%
 
31.3
%
 
SG&A expense
3,026

 
2,725

11.0
%
Depreciation and amortization
201

 
202

 
 
 
 
 
 
Operating Income
125

 
101

 
Operating margin
1.2
%
 
1.0
%
 
 
 
 
 
 
Interest income
5

 
5

 
Interest expense
(23
)
 
(24
)
 
Total other expense
(18
)
 
(19
)
 
 
 
 
 
 
Income before income tax expense
107

 
82

 
Income tax expense
37

 
7

 
Net Income
$
70

 
$
75

 
 
 
 
 
 
Net Income Per Share
 
 
 
 
     Basic and diluted
$
0.00

 
$
0.00

 
 
 
 
 
 
Weighted Average Shares Outstanding
 
 
 
 
Basic
16,082

 
16,008

 
Diluted
16,089

 
16,093

 





Sharps Compliance Corp. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)
(Unaudited)
 
 
 
 
 
September 30,
 
June 30,
 
2018
 
2018
 
 
 
 
ASSETS:
 
 
 
Current assets:
 
 
 
Cash
$
5,149

 
$
5,155

Accounts receivable, net
6,800

 
6,370

Inventory
4,144

 
3,986

Contract asset
278

 

Prepaid and other current assets
741

 
739

Total current assets
17,112

 
16,250

Property, plant and equipment, net
6,310

 
6,572

Long-term contract asset, net of current portion
60

 

Other assets
143

 
149

Goodwill
6,735

 
6,735

Intangible assets, net
3,536

 
3,525

Total assets
$
33,896

 
$
33,231

 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY:
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
1,894

 
$
1,500

Accrued liabilities
2,042

 
2,061

Current maturities of long-term debt
517

 
537

Contract liability
1,801

 
1,894

Total current liabilities
6,254

 
5,992

Long-term contract liability, net of current portion
462

 
470

Other long-term liabilities
137

 
130

Long-term deferred tax liability
25

 

Long-term debt, net of current portion
1,335

 
1,465

Total liabilities
8,213

 
8,057

Stockholders’ equity
25,683

 
25,174

Total liabilities and stockholders' equity
$
33,896

 
$
33,231






Sharps Compliance Corp. and Subsidiaries
Supplemental Customer Billing and Revenue Information
(in thousands)
(Unaudited)

 
 
Three-Months Ended September 30,
 
 
2018
 
% Total
 
2017
 
$ Change
 
%
BILLINGS BY MARKET:
 
 
 
 
 
 
 
 
 
 
Professional
 
$
3,674

 
35.7
%
 
$
3,101

 
$
573

 
18.5
 %
Retail
 
2,260

 
21.9
%
 
1,400

 
860

 
61.4
 %
Home Health Care
 
1,927

 
18.7
%
 
2,001

 
(74
)
 
(3.7
)%
Pharmaceutical Manufacturer
 
808

 
7.8
%
 
1,532

 
(724
)
 
(47.3
)%
Assisted Living
 
645

 
6.3
%
 
604

 
41

 
6.8
 %
Government
 
597

 
5.8
%
 
554

 
43

 
7.8
 %
Environmental
 
103

 
1.0
%
 
434

 
(331
)
 
(76.3
)%
Other
 
290

 
2.8
%
 
218

 
72

 
33.0
 %
Subtotal
 
$
10,304

 
100.0
%
 
$
9,844

 
$
460

 
4.7
 %
GAAP Adjustment *
 
(11
)
 
 
 
(161
)
 
150

 
 
Revenue Reported
 
$
10,293

 
 
 
$
9,683

 
$
610

 
6.3
 %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Represents the net impact of the revenue recognition adjustments to arrive at reported GAAP revenue. Customer billings include all invoiced amounts for products shipped or services rendered during the period reported. GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales, (ii) recognition of certain revenue associated with product returned for treatment and destruction and (iii) provisions for certain rebates, product returns and discounts to customers which are accounted for as reductions in sales in the same period the related sales are recorded. The difference between customer billings and GAAP revenue is reflected in the Company’s balance sheet as Contract Liability.





Sharps Compliance Corp. and Subsidiaries
Supplemental Customer Billing by Solution Information
(in thousands)
(Unaudited)

 
 
Three-Months Ended September 30,
 
 
2018
 
% Total
 
2017*
 
$ Change
 
%
BILLINGS BY SOLUTION:
 
 
 
 
 
 
 
 
 
Mailbacks
$
5,618

 
54.5
%
 
$
5,626

 
$
(8
)
 
(0.1
)%
Route-Based Pickup
2,128

 
20.7
%
 
1,761

 
367

 
20.8
 %
Unused Medications
1,639

 
15.9
%
 
1,172

 
467

 
39.8
 %
Third Party Treatment
102

 
1.0
%
 
434

 
(332
)
 
(76.5
)%
Other
 
817

 
7.9
%
 
851

 
(34
)
 
(4.0
)%
Total Billings By Solution
$
10,304

 
100.0
%
 
9,844

 
$
460

 
4.7
 %
 
 
 
 
 
 
 
 
 
 
 
*Certain prior year amounts have been reclassified to conform to current year presentation.






Sharps Compliance Corp. and Subsidiaries
Supplemental Customer Billing by Channel Information
(in thousands)
(Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
Three-Months Ended September 30,
 
 
2018
 
% Total
 
2017
 
$ Change
 
% Change
BILLINGS BY CHANNEL:
 
 
 
 
 
 
 
 
 
 
Direct Sales
 
$
4,625

 
44.9
%
 
$
5,328

 
$
(703
)
 
(13.2
)%
Distributors
 
3,357

 
32.6
%
 
2,768

 
589

 
21.3
 %
Inside and Online Sales
 
2,322

 
22.5
%
 
1,748

 
574

 
32.8
 %
Total Billings By Channel
 
$
10,304

 
100.0
%
 
$
9,844

 
$
460

 
4.7
 %
 
 
 
 
 
 
 
 
 
 
 





Sharps Compliance Corp. and Subsidiaries
Supplemental Table to Reconcile Net Income to EBITDA*
(in thousands)
(Unaudited)

 
Three-Months Ended
 
September 30,
 
2018
 
2017
 
 
 
 
Net Income
$
70

 
$
75

 
 
 
 
Income tax expense
37

 
7

Interest expense, net
18

 
19

Depreciation and amortization
391

 
390

 
 
 
 
EBITDA
$
516

 
$
491

 
 
 
 
 
 
 
 
*The Company defines earnings before interest, taxes, depreciation and amortization (“EBITDA”) as net income, plus income tax expense (benefit), net interest expense, and depreciation and amortization. Other companies may define EBITDA differently. EBITDA is presented because it is a financial measure that is frequently requested by third parties. However, EBITDA is not considered under generally accepted accounting principles as a primary measure of an entity’s financial results, and accordingly, EBITDA should not be considered an alternative to operating income, net income, or cash flows as determined under generally accepted accounting principles and as reported by the Company.




View differences made from one to another to evaluate Sharps Compliance Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sharps Compliance Corp.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account